Delanzomib (CEP-18770) is a potent and orally active chymotrypsin-like activity of the proteasome inhibitor with an IC50 of 3.8 nM. Delanzomib inhibits NF-kappaB activity, induces cancer cell apoptotic, and has strong antiangiogenic and anti-cancer activitie
Molecular Weight:
413.28
Purity:
98
CAS Number:
[847499-27-8]
Formula:
C21H28BN3O5
Target:
Apoptosis,NF-kappaB,Proteasome
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted